CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Single-Tracer FDG PET/CT Exam +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05680675
NCT05680675N/ACompleted
CompareCT.gov

Dual-Tracer Theranostic PET

University of Utah·interventional·Posted Jan 11, 2023·Updated Feb 6, 2025

In Brief

A clinical study evaluating Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE PET/CT Exam, and 2 other interventions for Neuroendocrine Tumors and Prostate Cancer. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuroendocrine Tumors, Prostate Cancer
CountriesUnited States
CollaboratorsMultiFunctional Imaging LLC, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 11, 2023
Enrollment StartDec 8, 2022
Primary CompletionJun 4, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.5 years ago

Interventions

Single-Tracer FDG PET/CT Examother

The PET technologist will administer approximately 15 millicuries (mCi) of FDG intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.

Single-Tracer Cu64-DOTATATE PET/CT Examother

The PET technologist will administer with approximately 4 mCi Cu64-DOTATATE intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.

Single-Tracer Ga68-DOTATATE PET/CT Examother

The PET technologist will administer with with approximately 5 mCi Ga68-DOTATATE intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.

Single-Tracer PSMA PET/CT Examother

The PET technologist will administer with with approximately 7 mCi Ga68-PSMA-11 intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.